Literature DB >> 9782694

Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas.

C M Brown1.   

Abstract

OBJECTIVE: To assess community pharmacists' experiences with the use of alternative therapies by their patients with chronic illnesses.
DESIGN: Mail survey.
SETTING: State of Texas. PARTICIPANTS: 142 community independent and chain pharmacists. MAIN OUTCOME MEASURES: Pharmacists' recollections about patients' use of alternative therapies.
RESULTS: Pharmacists estimated that 17% of their patients with chronic illnesses used some form of alternative therapy. A majority (66.9%) indicated that they have patients who used some type of alternative therapy for chronic conditions and that a majority (59.7%) of these patients consulted with them regarding those therapies. However, in only 11.1% of these cases did pharmacists document alternative therapy use in patients' pharmacy records. Pharmacists reported that 25.9% of these patients who use alternative therapies for chronic conditions were not compliant with their prescribed medication regimen. One-third (33.1%) of respondents indicated they knew of no patients who used alternative therapies, and 35.9% had never asked.
CONCLUSION: Pharmacists need information on patients' use of alternative therapies for chronic illnesses to make valid therapy decisions and to monitor outcomes. Future research should identify actions that pharmacists take to address drug-related problems among alternative therapy users and assess the impact of these actions on drug therapy-related outcomes.

Entities:  

Mesh:

Year:  1998        PMID: 9782694     DOI: 10.1016/s1086-5802(16)30374-6

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  9 in total

Review 1.  The ethics of dietary supplements and natural health products in pharmacy practice: a systematic documentary analysis.

Authors:  Heather Boon; Kristine Hirschkorn; Glenn Griener; Michelle Cali
Journal:  Int J Pharm Pract       Date:  2009-02

2.  Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews.

Authors:  Shade Olatunde; Heather Boon; Kristine Hirschkorn; Sandy Welsh; Jana Bajcar
Journal:  Res Social Adm Pharm       Date:  2009-07-29

3.  Antiretroviral adherence and use of alternative therapies among older HIV-infected adults.

Authors:  A K Wutoh; C M Brown; E K Kumoji; M S Daftary; T Jones; N A Barnes; N J Powell
Journal:  J Natl Med Assoc       Date:  2001 Jul-Aug       Impact factor: 1.798

Review 4.  U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review.

Authors:  Della Kwan; Kristine Hirschkorn; Heather Boon
Journal:  BMC Complement Altern Med       Date:  2006-09-19       Impact factor: 3.659

5.  Use of National Consumer Survey Data to Explore Perceptions of Complementary and Alternative Medicine.

Authors:  Alina Cernasev; Basma Gomaa; Keri Hager; Jon C Schommer; Lawrence M Brown
Journal:  Innov Pharm       Date:  2020-04-30

6.  Pattern and Factors Associated With the Utilization of Herbs As Medications Among Patients in a Tertiary Care Hospital in Western Saudi Arabia.

Authors:  Ahmad Alamoudi; Yazeid Alrefaey; Yazeed Asiri; Eyad Farrash; Fayssal Farahat; Syed Faisal Zaidi
Journal:  Cureus       Date:  2021-11-12

7.  Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies.

Authors:  Sireen A Shilbayeh
Journal:  Pharm Pract (Granada)       Date:  2011-12-12

8.  Pharmacists' attitudes and awareness towards the use and safety of herbs in Kuwait.

Authors:  Nada A Abahussain; Eman A Abahussain; Fawaz M Al-Oumi
Journal:  Pharm Pract (Granada)       Date:  2007-07

9.  The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain.

Authors:  Termeh Feinberg; Dina L Jones; Christa Lilly; Amna Umer; Kim Innes
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.